Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
Between 2016 and 2021, we retrospectively identified 42 patients receiving ≥1 dose of dalbavancin for osteomyelitis, skin and soft-tissue infection, endocarditis or bacteremia, or septic arthritis. Median antibiotic duration prior to dalbavancin administration was 7 days. Within 90 days, 93% achieve...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formato: | Livro |
Publicado em: |
Cambridge University Press,
2022-01-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Seja o primeiro a partilhar um comentário!